Article

Foldable intraocular telescope holds promise for patients with end-stage AMD

With approximately 14 million Americans with end-stage age-related macular degeneration (AMD), the latest developments in low vision aids for these patients is welcoming, noted Gholam A. Peyman, MD.

With approximately 14 million Americans with end-stage age-related macular degeneration (AMD), the latest developments in low vision aids for these patients is welcoming, noted Gholam A. Peyman, MD.

Dr. Peyman, professor of ophthalmology, Tulane University School of Medicine, New Orleans, described the steps leading up to the development of the Foldable Intraocular Telescope (FIT). He spoke during the Innovator's Session at the American Society of Cataract and Refractive Surgery annual meeting.

In 1988, he presented the concept behind FIT, which is basically a posterior chamber IOL with a telescopic zone and peripheral zone.

"The patient will be able to have full peripheral visual field without spectacles," Dr. Peyman said. "If the patient would like to read, he uses the plus lens in the telescope and the minus lens inside the eye. It provides 2.4x magnification."

From this concept, the foldable version, FIT, was developed with bifocal capabilities. This 5.8-mm foldable IOL system consists of a telescope measuring 1.5 mm in diameter and 3.5 mm in height. A 4.5-mm corneal incision is need for its implantation, he said.

"FIT provides patients with 3x magnification. For the surgeon it provides easier implantation," he said.

Dr. Peyman also discussed the development of a power-adjustable contact lens for the correction of myopia, hyperopia, and astigmatism. One of the advantages of this lens is the ability to correct higher-order aberrations, Dr. Peyman said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.